US Zika Vaccine Begins to Be Tested on Humans
Another vaccine against Zika virus will begin to be tested in humans. This is a formula that uses DNA from the virus and was developed by the US National Institute of Allergy and Infectious Diseases (NIAID).
At this stage of testing it was applied to 80 American volunteers aged 18-35. Patients received the first dose this Tuesday (2). The goal is to see if this vaccine is safe for humans and also to evaluate the immunization response with the vaccine.
In a press conference, NIAID director Anthony Fauci said the first results should be available by the end of 2016 "If the response has been satisfactory to clinical trials, phase two could be started in countries endemic for the Zika virus in 2017.
The United States is increasingly concerned about the Zika virus epidemic, due to cases related to sexual transmission throughout the country, and new cases of local mosquito transmission in Florida.
Prior to this, partner laboratories Inovio (from the United States) and GeneOne Life Sciences (South Korea) also began human trials of a vaccine against Zika virus.
Allied to good health and well functioning immune system, vitamins can not miss in the diet. According to IBGE, however, most Brazilians do not care much about them. A survey conducted by the institution pointed out that 98% of the Brazilian population does not consume the ideal amount of vitamins per day and 92%, does not eat fruits frequently.
When the hair starts to thin, the panic arises. You can often see the wires scattered on clothes, on the pillow and on the brush, but in others, it only seems that the volume has diminished. And that's when the doubt arises: is it hair loss or baldness? According to trichologist Sheila Belotti, it is normal for a person to lose between 50 and 100 threads per day.